Literature DB >> 15133645

HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms.

Thomas Vauvert F Hviid1, Roberta Rizzo, Ole B Christiansen, Loredana Melchiorri, Anette Lindhard, Olavio R Baricordi.   

Abstract

The expression and importance of the non-classical human leukocyte antigen (HLA) class Ib gene, HLA-G, at the feto-maternal interface have been recognized. The HLA-G molecule is almost monomorphic and expressed in both membrane-bound and soluble isoforms. It has been shown to inhibit NK-mediated cell lysis and influence cytokine expression. Recently, a possible boarder immunoregulatory function of HLA-G also in adult life has been recognized. HLA-G gene polymorphism has been linked to differences in gene expression profile of alternatively spliced HLA-G transcripts and levels of specific HLA-G mRNA isoforms. On this background it is of general interest to further elucidate any associations between HLA-G polymorphism and protein expression. We have HLA-G genotyped 85 individuals attending IVF treatment, and further studied sHLA-G1/HLA-G5 and interleukin-10 (IL-10) in serum samples. In 21% of the serum samples sHLA-G1/HLA-G5 could be detected. There was no correlation between sHLA-G1/HLA-G5 and IL-10 concentrations in serum. Soluble HLA-G1/HLA-G5 was not detected in any samples homozygous for a 14-bp insertion polymorphism in exon 8 of the 3'-untranslated region (3'UTR) of the HLA-G gene ( P=0.03; Fisher's exact test). Polymorphisms in the 5'-upstream regulatory region (5'URR) of the HLA-G gene were also studied. In conclusion, this study indicates that polymorphisms in the 3'UTR and the 5'URR of the HLA-G gene may influence the expression of sHLA-G of possible importance in pathological pregnancies and also in organ transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133645     DOI: 10.1007/s00251-004-0673-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  40 in total

1.  Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8.

Authors:  S Fournel; M Aguerre-Girr; X Huc; F Lenfant; A Alam; A Toubert; A Bensussan; P Le Bouteiller
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

2.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

3.  HLA-G polymorphisms in couples with recurrent spontaneous abortions.

Authors:  T V Hviid; S Hylenius; A M Hoegh; C Kruse; O B Christiansen
Journal:  Tissue Antigens       Date:  2002-08

4.  Polymorphism in the regulatory region located more than 1.1 kilobases 5' to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene.

Authors:  T V Hviid; S Sørensen; N Morling
Journal:  Hum Immunol       Date:  1999-12       Impact factor: 2.850

5.  Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia.

Authors:  D S Goldman-Wohl; I Ariel; C Greenfield; D Hochner-Celnikier; J Cross; S Fisher; S Yagel
Journal:  Mol Hum Reprod       Date:  2000-01       Impact factor: 4.025

6.  An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes.

Authors:  M Kirszenbaum; P Moreau; E Gluckman; J Dausset; E Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  HLA-G has a concentration-dependent effect on the generation of an allo-CTL response.

Authors:  K Kapasi; S E Albert; S Yie; N Zavazava; C L Librach
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

8.  Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.

Authors:  Catherine Menier; Berta Saez; Vaclav Horejsi; Silvia Martinozzi; Irene Krawice-Radanne; Sylvie Bruel; Caroline Le Danff; Murielle Reboul; Ivan Hilgert; Michèle Rabreau; Mur Luis Larrad; Marika Pla; Edgardo D Carosella; Nathalie Rouas-Freiss
Journal:  Hum Immunol       Date:  2003-03       Impact factor: 2.850

9.  A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.

Authors:  T Fujii; A Ishitani; D E Geraghty
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G.

Authors:  A Steinborn; V Rebmann; A Scharf; C Sohn; H Grosse-Wilde
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

View more
  47 in total

Review 1.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-04-28       Impact factor: 4.132

2.  HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.

Authors:  Roberta Rizzo; Valentina Audrito; Paola Vacca; Davide Rossi; Davide Brusa; Marina Stignani; Daria Bortolotti; Giovanni D'Arena; Marta Coscia; Luca Laurenti; Francesco Forconi; Gianluca Gaidano; Maria Cristina Mingari; Lorenzo Moretta; Fabio Malavasi; Silvia Deaglio
Journal:  Haematologica       Date:  2013-12-20       Impact factor: 9.941

3.  Relationship between HLA-G polymorphism and susceptibility to recurrent miscarriage: a meta-analysis of non-family-based studies.

Authors:  Wei Fan; Shangwei Li; Zhongying Huang; Qiong Chen
Journal:  J Assist Reprod Genet       Date:  2013-12-19       Impact factor: 3.412

4.  HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction.

Authors:  Elnaz Mosaferi; Jafar Majidi; Mojdeh Mohammadian; Zohreh Babaloo; Amir Monfaredan; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2013-08-20

Review 5.  The HLA-G 14-bp polymorphism and recurrent implantation failure: a meta-analysis.

Authors:  Wei Fan; Zhongying Huang; Shangwei Li; Zhun Xiao
Journal:  J Assist Reprod Genet       Date:  2017-07-13       Impact factor: 3.412

Review 6.  HLA class Ib in pregnancy and pregnancy-related disorders.

Authors:  Gry Persson; Wenna Nascimento Melsted; Line Lynge Nilsson; Thomas Vauvert F Hviid
Journal:  Immunogenetics       Date:  2017-07-11       Impact factor: 2.846

7.  Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversity.

Authors:  A Sabbagh; P Luisi; E C Castelli; L Gineau; D Courtin; J Milet; J D Massaro; H Laayouni; P Moreau; E A Donadi; A Garcia
Journal:  Genes Immun       Date:  2013-12-19       Impact factor: 2.676

Review 8.  Soluble HLA-G: Are they clinically relevant?

Authors:  Vito Pistoia; Fabio Morandi; Xinhui Wang; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2007-07-31       Impact factor: 15.707

9.  The maternal HLA-G 1597ΔC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women.

Authors:  Dagan A Loisel; Christine Billstrand; Kathleen Murray; Kristen Patterson; Tinnakorn Chaiworapongsa; Roberto Romero; Carole Ober
Journal:  Mol Hum Reprod       Date:  2012-09-21       Impact factor: 4.025

Review 10.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.